City of Hope

www.cityofhope.org

 

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
E

2020 SOHO Update on CAR-T for R/R AML: What Are the Current Limitations? How Can We Improve the Efficacy and Safety?

By Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020) FEATURING Elizabeth Budde
By Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020) FEATURING Elizabeth Budde
26 views
December 11, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
Leukemia
08:26
City of Hope

Primary Analysis of TRANSCEND CLL 004 - Liso-Cel in R/R CLL/SLL

Feat. T. Siddiqi
08:35
SOHO 2023 Eleventh Annual Meeting

SOHO 2023 Primary Analysis of the Phase 1/2, Single-Arm, Multicenter…

Feat. T. Siddiqi
06:23
City of Hope

TKI-BiTE Combo in Ph+ALL: Integrating Expert Opinion With Clinical T…

Feat. I. Aldoss
06:57
ASH 2022 Conference Coverage

ASH 2022 NX-2127-001, a First-in-Human Trial of NX-2127, a BTK-Targe…

Feat. A. Danilov
06:20
ASH 2022 Conference Coverage

Consolidation With Allogeneic HCT Improved Survival Outcomes of Adul…

Feat. I. Aldoss
09:33
City of Hope

Assessing Comorbidities in CLL

Feat. A. Danilov
18:28
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Update on Optimizing Lymphodepletion Prior to CAR-T Therap…

Feat. E. Budde
33:39
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Update on CAR-T for R/R AML: What Are the Current Limitati…

Feat. E. Budde
25:04
City of Hope

How to Sequence Novel Agents in CLL

Feat. T. Siddiqi